Table 3.
Multiple logistic regression analysis (with simultaneous entry of variables) identifying correlates of prescription drug misuse (N = 723)
| Variable | b | SE | Wald | P | OR | [95% CI] |
| Male vs. female | 0.28 | 0.31 | 0.80 | .37 | 1.3 | [0.72, 2.4] |
| White vs. African American | 1.0 | 0.30 | 12.4 | .00 | 2.8 | [1.6,5.0] |
| Latino/Latina vs. African American | 0.07 | 0.57 | 0.02 | .90 | 1.1 | [0.36, 3.2] |
| Other races vs. African American | 1.2 | 0.43 | 7.4 | .01 | 3.3 | [1.4, 7.6] |
| Age, in years | 0.50 | 0.10 | 24.0 | .00 | 1.6 | [1.3, 2.0] |
| Small town vs. other levels of urbanization | 0.41 | 0.22 | 3.4 | .07 | 1.5 | [0.97, 2.3] |
| History of mental illness | 0.08 | 0.22 | 0.12 | .73 | 1.1 | [0.70, 1.7] |
| Lifetime inhalant user | 1.0 | 0.25 | 16.5 | .00 | 2.8 | [1.7, 4.5] |
| Cocaine/crack use | 0.31 | 0.28 | 1.2 | .27 | 1.7 | [0.79, 2.4] |
| Lifetime marijuana user | 2.2 | 0.56 | 15.5 | .00 | 9.2 | [3.0, 27.6] |
| Lifetime LSD user | 1.5 | 0.29 | 24.9 | .00 | 4.3 | [2.4, 7.7] |
| MAYSI-2 substance-related problems | 0.07 | 0.05 | 1.9 | .17 | 1.1 | [0.97, 1.2] |
| BSI Global Severity Index | 0.00 | 0.00 | 0.17 | .68 | 1.0 | [0.99, 1.0] |
| PPI-SV carefree nonplanfulness | 0.04 | 0.03 | 1.6 | .21 | 1.0 | [0.98, 1.1] |
| PPI fearlessness | -0.03 | 0.02 | 1.4 | .24 | 0.97 | [0.93, 1.0] |
| SRD property crimes | 0.02 | 0.01 | 2.1 | .15 | 1.0 | [0.99, 1.0] |
| APSD Impulsivity Scale | 0.13 | 0.06 | 4.8 | .03 | 1.1 | [1.0,1.3] |
| MAYSI-2 suicidal ideation | -0.08 | 0.06 | 2.0 | .16 | 0.93 | [0.83, 1.0] |
| MAYSI-2 traumatic experiences | 0.03 | 0.08 | 0.11 | .74 | 1.0 | [0.89, 1.2] |
Notes: Bold indicates statistical significance at the p < .05 level. OR = odds ratio; CI = confidence interval; LSD = lysergic acid diethylamide; MAYSI-2 = Massachusetts Youth Screening Instrument—Second Version; BSI = Brief Symptom Inventory; PPI-SV = Psychopathic Personality Inventory—Short Version; SRD = Self-Report of Delinquency; APSD = Antisocial Process Screening Device.